Protagenic Therapeutics Inc [NASDAQ: PTIX] closed the trading session at $3.6 on 2025-08-29. The day’s price range saw the stock hit a low of $3.53, while the highest price level was $3.6695.
The stocks have a year to date performance of -59.76 percent and weekly performance of -15.09 percent. The stock has been moved at -15.69 percent over the last six months. The stock has performed 22.45 percent around the most recent 30 days and changed -6.49 percent over the most recent 3-months.
If compared to the average trading volume of 2.73M shares, PTIX reached to a volume of 154119 in the most recent trading day, which is why market watchdogs consider the stock to be active.
PTIX stock trade performance evaluation
Protagenic Therapeutics Inc [PTIX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -15.09. With this latest performance, PTIX shares gained by 22.45% in over the last four-week period, additionally sinking by -15.69% over the last 6 months – not to mention a drop of -47.52% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PTIX stock in for the last two-week period is set at 53.27, with the RSI for the last a single of trading hit 0.62, and the three-weeks RSI is set at 0.52 for Protagenic Therapeutics Inc [PTIX]. The present Moving Average for the last 50 days of trading for this stock 3.35, while it was recorded at 3.91 for the last single week of trading, and 4.77 for the last 200 days.
Protagenic Therapeutics Inc (PTIX) Capital Structure & Debt Analysis
Protagenic Therapeutics Inc (PTIX) Efficiency & Liquidity Metrics
Protagenic Therapeutics Inc (PTIX) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Protagenic Therapeutics Inc. (PTIX) effectively leverages its workforce, generating an average of -$1746666.67 per employee. The company’s liquidity position is robust, with a Current Ratio of 0.86% and a Quick Ratio of 0.86%, indicating strong ability to cover short-term liabilities.
Protagenic Therapeutics Inc [PTIX]: Institutional Ownership
There are presently around $12.57%, or 14.16%% of PTIX stock, in the hands of institutional investors.
